Search

The VI edition of the SME of the year awards was held in Bilbao on 18 July. These awards recognise essential aspects of the contribution to society and the economy of SMEs, which make up 99.8% of the

ALGAVILLAGE, proyecto conjunto de la compañía británica Firglas y la biotecnológica almeriense Biorizon Biotech, avanza firme con la construcción de su planta de microalgas en Carboneras (Almería)

Oryzon invests $8.1 million in R&D in the first half 2022

To explore Oryzon’s HDAC6 inhibitors on Charcot-Marie-Tooth disease CMTRF to provide funding for in vivo efficacy tests in CMT preclinical model

GENESIS Biomed will be the managing entity of the vehicle

This new launch follows a trend of expansion of the Spanish brand after its success in Europe and the Americas, with a significant presence in countries such as Mexico, Colombia and Argentina. Today

PVPHARM, a leading company in specialized pharmacovigilance and clinical safety services, has a group of experts that can manage CTIS on behalf of any clinical trial sponsor, and related tasks

The company plans to continue pushing forward the development of in silico enzyme discovery and design projects in the United States, especially in the area of the Life Sciences

Oryzon and NCI will collaborate to assess the safety and efficacy of iadademstat in oncology patients with different hematological and solid tumors

Almirall recently announced topline results from one-year analyses of the efficacy and safety of lebrikizumab, an investigational IL-13 inhibitor for the treatment of patients with moderate-to-severe

The event made public the winning projects that put the patient at the centre of the healthcare system unveiled

The analysis focuses on genomic data provided by various genomic technologies

BCN HEALTH presents the poster "Increased baseline comorbidity burden including liver severity among HDV/HBV coinfection versus HBV monoinfection patients – analysis from National Hospital Discharge

Extension led by Pfizer with participation from new investors Walleye Capital and Asabys Partners as well as existing investors

The Venture Centre of Excellence, a public-private co-investment programme of EIT Health and the European investment Fund (EIF) to empower finance for European health small and medium size enterprises